Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

Share Price is delayed by 15 minutes
Get Live Data
271.40    -0.70 (-0.26%)
Bid:
270.30
Ask:
270.90
Spread: 0.60 (0.222%)
Market Cap: £2.93b
WPP Live PriceLast checked at - London Stock Exchange

Intraday WPP Share Chart

Executive Share Awards

15 May 2020 11:01

RNS Number : 0691N
WPP PLC
15 May 2020
 

FOR IMMEDIATE RELEASE 15 May 2020

 

WPP plc ("WPP")

Executive Share Awards

 

Mark Read

WPP's Executive Directors' annual bonuses for 2019 were delivered in the form of a cash award and, for Mark Read, a deferred share award, with the shares comprising 40% of the total bonus achieved. The Executive Share Award (ESA) will vest after a minimum of two years, together with additional shares in respect of accrued dividends. The award is subject to continued employment and malus and clawback provisions. The 2019 ESA award to Mark Read was granted on 14 May 2020 over 97,523 WPP shares.

Details of the Executive Directors' bonuses were published in the WPP 2019 Annual Report and Accounts.

John Rogers

As announced on 1 October 2019, John Rogers has been granted awards under the WPP Share Plans. The awards are to compensate John for the loss of share-based incentives that were forfeited on his departure from Sainsbury's and are of equivalent value and form as the awards forfeited. The awards are all subject to continued employment as well as malus and clawback provisions and restrictive covenants.

Furthermore, the Executive Performance Share Plan (EPSP) awards are subject to a relative Total Shareholder Return (TSR) performance condition, with a Return on Invested Capital (ROIC) underpin. TSR performance will be compared to companies representing the most relevant, listed global competitors, with performance below median resulting in zero vesting. Performance between median and upper decile provides for a vesting opportunity of between 15% and 100%. The awards will vest subject to a ROIC underpin of an average of 7.5% over the performance period. The Compensation Committee has an overriding discretion to determine the extent to which the award will vest.

The EPSP awards were granted to John Rogers on 14 May 2020 as 182,744 and 243,934 nil cost options, which are exercisable over WPP shares or ADRs and also incorporate dividend awards. The extent to which the options will become exercisable in 2021 and 2022 respectively will depend on WPP's performance, as described above, over the period from 1 January 2019 to 31 December 2020 and the period from 1 January 2019 to 31 December 2021.

John has also been granted awards over 66,176 WPP shares, vesting in May 2021 and 52,438 WPP shares, vesting in November 2021. These awards incorporate dividend awards and replicate deferred bonus and deferred share awards John forfeited on his departure from Sainsbury's.

 

At today's date, Mark Read's shareholding in WPP is 296,976 ordinary shares and John Rogers does not currently hold ordinary shares in WPP.

 

 

Contact:

Chris Wade, WPP

+44 (0)20 7282 4600

 

Richard Oldworth, Buchanan Communications

+44 (0)7710 130634

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEANSSFSPEEEA
Date   Source Headline
18th May 20227:00 amRNSTransaction in Own Shares
17th May 20227:00 amRNSTransaction in Own Shares
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20221:01 pmRNSExecutive Share Award
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20224:31 pmRNSNotification of Major Holdings
11th May 20227:00 amRNSTransaction in Own Shares
10th May 20227:00 amRNSTransaction in Own Shares
9th May 20227:00 amRNSTransaction in Own Shares
6th May 20227:00 amRNSTransaction in Own Shares
5th May 20227:00 amRNSTransaction in Own Shares
4th May 20227:00 amRNSTransaction in Own Shares
3rd May 202212:50 pmRNSTotal Voting Rights and Capital
3rd May 20227:00 amRNSTransaction in Own Shares
29th Apr 20227:00 amRNSTransaction in Own Shares
28th Apr 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSFirst Quarter Trading Update
27th Apr 20227:00 amRNSTransaction in Own Shares
26th Apr 20227:00 amRNSTransaction in Own Shares
25th Apr 20227:00 amRNSTransaction in Own Shares
22nd Apr 20227:00 amRNSTransaction in Own Shares
21st Apr 20227:00 amRNSTransaction in Own Shares
20th Apr 20222:59 pmRNSNotification of Trading Update
20th Apr 20227:00 amRNSTransaction in Own Shares
19th Apr 20227:00 amRNSTransaction in Own Shares
14th Apr 20227:00 amRNSTransaction in Own Shares
13th Apr 20227:00 amRNSTransaction in Own Shares
12th Apr 20227:00 amRNSTransaction in Own Shares
11th Apr 20227:00 amRNSTransaction in Own Shares
8th Apr 20227:00 amRNSTransaction in Own Shares
7th Apr 20227:00 amRNSTransaction in Own Shares
6th Apr 20226:07 pmRNSAnnual Report 2021 on Form 20-F
6th Apr 20227:00 amRNSTransaction in Own Shares
5th Apr 20224:30 pmRNSNotification of Major Holdings
5th Apr 20227:00 amRNSTransaction in Own Shares
4th Apr 20227:00 amRNSTransaction in Own Shares
1st Apr 20221:00 pmRNSTotal Voting Rights and Capital
1st Apr 20227:00 amRNSTransaction in Own Shares
31st Mar 20223:30 pmRNSAnnual Report 2021 and AGM 2022
31st Mar 20227:00 amRNSTransaction in Own Shares
30th Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20224:54 pmRNSBoard Committee membership changes
29th Mar 20223:45 pmRNSNotification of Major Holdings
29th Mar 20222:10 pmRNSExecutive Performance Share Awards
29th Mar 20227:00 amRNSTransaction in Own Shares
28th Mar 20227:00 amRNSTransaction in Own Shares
25th Mar 20227:00 amRNSTransaction in Own Shares
24th Mar 20228:00 amRNSShare buyback programme
23rd Mar 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.